Oseltamivir phosphate

Oseltamivir phosphate is a novel neuraminidase (NA) inhibitor with high selectivity, which can be used in the treatment and prevention of influenza virus infection, bronchitis associated with infection, pneumonia, general pain, fever and severe diseases, especially against ChemicalbookA and influenza B virus. Oseltamivir was listed in Switzerland in 1999, and a large number of clinical practices have proved that it has the advantages of high efficiency, low resistance, good patient tolerance and high safety, and is widely used in clinical prevention and treatment of influenza.